Abcellera Biologics

-$1.35 (-5.21%) Today
+$0.30 (+1.22%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ABCL and other stocks, options, and ETFs commission-free!

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.

CEO
Carl Lars G. Hansen
Employees
206
Headquarters
Vancouver, British Columbia
Founded
2012

ABCL Key Statistics

Market Cap
6.69B
Price-Earnings Ratio
29.39
Dividend Yield
—
Average Volume
2.07M
High Today
$26.60
Low Today
$24.20
Open Price
$26.60
Volume
3.57M
52 Week High
$71.91
52 Week Low
$23.20

ABCL Earnings

$0.00
$0.20
$0.41
$0.61
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure